Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

被引:287
作者
Miao, H
Wei, BR
Peehl, DM
Li, Q
Alexandrou, T
Schelling, JR
Rhim, JS
Sedor, JR
Burnett, E
Wang, BC
机构
[1] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, Cleveland, OH 44109 USA
[2] Case Western Reserve Univ, Sch Med, Ireland Canc Ctr, Cleveland, OH 44109 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44109 USA
[4] Stanford Univ, Dept Urol, Stanford, CA 94305 USA
[5] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/35074604
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation(1,2). However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation(3,4) or to transform rodent fibroblasts(5), indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and Vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.
引用
收藏
页码:527 / 530
页数:4
相关论文
共 50 条
[21]   Tyrosine kinase/p21(ras)/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells [J].
Migliaccio, A ;
DiDomenico, M ;
Castoria, G ;
deFalco, A ;
Bontempo, P ;
Nola, E ;
Auricchio, F .
EMBO JOURNAL, 1996, 15 (06) :1292-1300
[22]   The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway [J].
Cortez, D ;
Stoica, G ;
Pierce, JH ;
Pendergast, AM .
ONCOGENE, 1996, 13 (12) :2589-2594
[23]   Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade [J].
Avruch, J ;
Khokhlatchev, A ;
Kyriakis, JM ;
Luo, ZJ ;
Tzivion, G ;
Vavvas, D ;
Zhang, XF .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 :127-155
[24]   Kinase suppressor of ras inhibits the activation of ERK MAP kinase by insulin, activated ras, and ras effectors [J].
Fulton, J ;
Joneson, T ;
Volle, D ;
Chaika, O ;
Bar-Sagi, D ;
Lewis, R .
DIABETES, 1998, 47 :A21-A21
[25]   EPHA4 RECEPTOR TYROSINE KINASE AND REGULATION OF THE ASTROCYTIC CYTOSKELETON [J].
Turnley, A. M. ;
Puschmann, T. .
JOURNAL OF NEUROCHEMISTRY, 2009, 110 :212-213
[26]   SIGNAL-TRANSDUCTION PATHWAY INITIATED BY ACTIVATION OF THE SEVENLESS TYROSINE KINASE RECEPTOR [J].
SIMON, MA ;
CARTHEW, RW ;
FORTINI, ME ;
GAUL, U ;
MARDON, G ;
RUBIN, GM .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1992, 57 :375-380
[27]   The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors [J].
Wu, Yinxin ;
Du, Zhuoying ;
Mou, Jie ;
Qiu, Xinyan ;
Chen, Jinlan ;
Cai, Sanjin ;
Ren, Dongming ;
Xiao, Fangxiang ;
Zhou, Gang ;
Yuan, Chengfu .
CURRENT MEDICINAL CHEMISTRY, 2023, 30 (20) :2340-2353
[28]   The role of the EphA3 receptor tyrosine kinase in heart development [J].
Fawkes, AL ;
Pniak, K ;
Brown, A .
CIRCULATION, 2000, 102 (18) :109-109
[29]   THE TYROSINE KINASE RECEPTOR EPHA2 IS A DRUG TARGET FOR OSTEOARTHRITIS [J].
Ferrao Blanco, M. N. ;
Bastiaansen-Jenniskens, Y. M. ;
Narcisi, R. ;
Chambers, M. G. ;
Pitsillides, A. A. ;
van Osch, G. J. .
OSTEOARTHRITIS AND CARTILAGE, 2020, 28 :S36-S37
[30]   Progranulin and the receptor tyrosine kinase EphA2, partners in crime? [J].
Chitramuthu, Babykumari ;
Bateman, Andrew .
JOURNAL OF CELL BIOLOGY, 2016, 215 (05) :603-605